as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
1.28%
Downside
1.70%
Upside
52 Week's Low
52 Week's High
14.26%
Downside
225.53%
Upside
Check Health Catalyst Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$167.6M
EPS (TTM)
0.2052
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.84
Industry PE ratio
-3.2295762711864406
PEG Ratio
0EBITDA
-16.8M
Revenue (TTM)
316.1M
Profit Margin
-34.05%
Return On Equity TTM
-31.33%
Track how Health Catalyst Inc P/E has moved over time to understand its valuation trends.
Health Catalyst Inc in the last 5 years
Lowest (-148.87x)
June 30, 2023
Today (-4.84x)
December 20, 2025
Industry (-3.23x)
December 20, 2025
Highest (149.23x)
September 30, 2023
Today’s Price to Earnings Ratio: -4.84x
Compare market cap, revenue, PE, and other key metrics of Health Catalyst Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $167.6M | -94.4% | -4.84 | -34.05% | |
| BUY | $8.3B | 46.34% | 43.81 | 14.86% | |
| BUY | $35.9B | -19.53% | 42.51 | 27.93% | |
| BUY | $37.7B | NA | 17.08 | 10.95% | |
| NA | $11.1B | NA | -25.89 | -18.45% |
The Health Catalyst Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Health Catalyst Inc investment value today
Current value as on today
₹38,560
Returns
Returns from Health Catalyst Inc Stock
Dollar Returns*
₹5,415 (+5.41%)
Based on 23 analysts
73.91%
Buy
26.09%
Hold
0.00%
Sell
Based on 23 analysts, 73.91% of analysts recommend a 'BUY' rating for Health Catalyst Inc. Average target price of $3.94
Get share price movements and forecasts by analysts on Health Catalyst Inc.
What analysts predicted
40.36%UPSIDE
Target Price
$3.94
Current Price
$2.35
Analyzed by
23 Analysts
Target
$3.94
Health Catalyst Inc target price $3.94, a slight upside of 40.36% compared to current price of $2.35. According to 23 analysts rating.
Search interest for Health Catalyst Inc Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:52% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -40.97M → -22.22M (in $), with an average increase of 84.3% per quarter
Best in 3 Years
![]()
In the last 3 years, HCAT has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 1 year, Tempus Ai has given 81.4% return, outperforming this stock by 148.3%
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 80.72M → 76.32M (in $), with an average decrease of 5.5% per quarter
Price Dip
![]()
In the last 1 year, HCAT stock has moved down by -66.9%
| Organisation | Health Catalyst Inc |
| Headquarters | 10897 South River Front Parkway, South Jordan, UT, United States, 84095 |
| Industry | Technology Services |
| CEO | Mr. Daniel D. Burton |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Jeffrey P. Selander | Senior Vice President of International |
Mr. Benjamin Landry | General Counsel & Secretary of the Board |
Mr. Benjamin Albert | President & COO |
Ms. Linda Llewelyn | Chief People Officer |
Mr. Kevin Freeman | Chief Commercial Officer |
Mr. Matt Hopper | Senior VP of Finance & Head of Investor Relations |
Ms. Amanda Flanders | Senior Vice President of Marketing & Communications |
Mr. Kyle J. Salyers | Chief Strategy Officer & Senior VP of Corporate Development |
Mr. Daniel D. Burton | CEO & Director |
Mr. Jason Alger | Chief Financial Officer |
Health Catalyst Inc share price today is $2.35 as on at the close of the market. Health Catalyst Inc share today touched a day high of $2.39 and a low of $2.32.
Health Catalyst Inc share touched a 52 week high of $7.65 on and a 52 week low of $2.02 on . Health Catalyst Inc stock price today i.e. is closed at $2.35,which is 69.28% down from its 52 week high and 16.63% up from its 52 week low.
Health Catalyst Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Health Catalyst Inc (HCAT) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Health Catalyst Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Health Catalyst Inc share’s latest price of $2.35 as on December 20, 2025 at 2:29 am IST, you will get 4.2553 shares of Health Catalyst Inc. Learn more about
fractional shares .
Health Catalyst Inc stock has given -94.4% share price returns and 22.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?